|
Symbol Name ID |
Tab2
TGF-beta activated kinase 1/MAP3K7 binding protein 2 MGI:1915902 |
Excel File
| Allelic Composition Genetic Background |
Annotated Term | Reference |
| Tab2tm2.1Aki/Tab2tm2.1Aki Tab3tm1Aki/Tab3tm1Aki Cd19tm1(cre)Cgn/Cd19+ involves: 129P2/OlaHsd * C57BL/6 |
abnormal B cell physiology | J:195289 |
| abnormal immune serum protein physiology | J:195289 | |
| decreased B cell proliferation | J:195289 | |
| decreased B-1a cell number | J:195289 | |
| decreased circulating interleukin-6 level | J:195289 | |
| decreased IgD level | J:195289 | |
| decreased IgE level | J:195289 | |
| decreased IgG level | J:195289 | |
| decreased immunoglobulin level | J:195289 | |
| decreased mature B cell number | J:195289 | |
| decreased plasma cell number | J:195289 | |
| increased B cell apoptosis | J:195289 | |
| Tab2tm2.1Aki/Tab2tm2.1Aki Tab3tm1Aki/Tab3tm1Aki Lyz2tm1(cre)Ifo/Lyz2+ involves: 129P2/OlaHsd * C57BL/6 |
normal immune system phenotype | J:195289 |
| Tab2tm2.1Aki/Tab2tm2.1Aki Tnfrsf1atm1Mak/Tnfrsf1atm1Mak Tg(Tek-cre)12Flv/0 involves: 129P2/OlaHsd * C3H * C57BL/6 |
abnormal vascular development | J:191285 |
| embryonic lethality during organogenesis, complete penetrance | J:191285 |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
|
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 04/09/2024 MGI 6.23 |
|
|
|
||
Analysis Tools